Skip to main content

Or 34,00 After 66% tax deduction

I make a monthly donation I make an IFI donation
Research, science & health

Our pupil reveals elements of our imagination

Published on: 20/04/2022 Reading time: 1 min
image
Retour à la recherche

A collaboration between Australian (University of New South Wales and Macquarie University) and French (Paris Brain Institute) researchers has found that variations in the diameter of our pupil reveal the sensory intensity of our mental imagination, such as the brightness of an imagined scene. These results, published in ELife, also provide the first physiological validation of aphantasia, the absence of mental visualisation.

Closing your eyes and visualising a landscape, a picture, a face in your head... this faculty, visual or mental imagery, may seem obvious to many of us.  However, it is not shared by everyone. It is estimated that around 3% of people are aphantasic, i.e. they do not possess this mental visualisation ability.

Today, visual imagery is often determined subjectively by asking a participant directly to describe their ability to visualise objects mentally. We lacked an objective tool to access an individual's mental imagery capacity.

Dr. Thomas Andrillon (Inserm) One of the authors of the article

When we see an object with our eyes, our pupils adapt to it. Their diameter varies according to the brightness outside, but studies have shown that it also adapts to the interpretation of an image. Thus, the pupil’s diameter is smaller for a black-and-white image depicting a sunny beach than for a moon-lit landscape, even when the images were manipulated to have the same luminance: the eye uses the context to approximate the expected level of luminance.

The pupillary reflex is an adaption that optimises the amount of light hitting the retina. And while it was already known that imagined objects can evoke so-called ‘endogenous’ changes in pupil size, we were surprised to see more dramatic changes in those reporting more vivid imagery. This really is the first biological, objective test for imagery vividness.

Professor Joel Pearson senior author on the paper

To explore this link between pupillary response and mental imagery, a group of Australian and French researchers set up two series of experiments. In the first, they presented participants with no visual imagery disorders with a series of geometric shapes varying in complexity and luminance, i.e. light intensity. The subjects were then asked to mentally visualise these shapes for 5 seconds. At the same time, their pupils were recorded using two cameras mounted on glasses. In a second phase, the researchers carried out the same study with aphantasic patients, who report no or limited mental imagery capacity.

The results show that the pupil diameter of the control subjects reacts both to the cognitive effort generated by the mental imagery and to the luminance of the visualised object. Furthermore, the pupil response to luminance was predictive of the subjective quality of the mental image reported by the subjects, i.e. how accurate they considered the image to be in their thoughts. In contrast, aphantasic subjects showed a smaller restriction of pupil diameter for more complex shapes but not for luminance.

Our pupils are known to get larger when we are doing a more difficult task. Imagining four objects simultaneously is more difficult than imagining just one. The pupils of those with aphantasia dilated when they imagined four shapes compared to one, but did not change based on the whether the shapes were bright or dark. This indicated that the participants with aphantasia were indeed trying to imagine in this experiment, just not in a visual way.

Lachlan Kay Phd candidate in the Future Minds Lab, UNSW

Sources

https://pubmed.ncbi.nlm.nih.gov/35356890/
Kay L, Keogh R, Andrillon T, Pearson J.Elife. 2022 Mar 31

Our news on the subject

Sclérose en plaques : identification d’une nouvelle molécule favorisant la remyélinisation
Multiple Sclerosis: Identification of a Molecule that Promotes Repair of the Nervous System
A molecule previously studied in the context of sleep disorders and attention deficit hyperactivity disorder (ADHD) is now, for the first time, revealing its potential in experimental models of multiple sclerosis (MS): it protects neurons and...
01.27.2026 Research, science & health
VignetteActu WBHF 2026
World Brain Health Forum 2026
More than one in three people will experience a brain disorder at some point in their lives. This reality, identified by the World Health Organization as a major public health priority, calls for unprecedented international mobilization. It is...
01.12.2026 Events
Une nouvelle approche pour évaluer les patients en état de conscience altérée
A New Approach to Assessing Patients with Disorders of Consciousness
In intensive care units, some patients who appear unconscious occupy a gray zone in their relationship to the world. To better diagnose them and predict their recovery potential, Dragana Manasova, Jacobo Sitt, and their colleagues have developed an...
01.08.2026 Research, science & health
Ne plus penser à rien : vers une signature cérébrale du blanc mental
Not Thinking About Anything: Toward a Brain Signature of Mind Blanking
What if the flow of our thoughts occasionally just stopped? Esteban Munoz-Musat, Lionel Naccache, Thomas Andrillon, and their colleagues at Paris Brain Institute and Monash University in Melbourne show that the sensation of “thinking about nothing”...
12.26.2025 Research, science & health
Deux nouvelles certifications pour les plateformes de l’Institut du Cerveau
Two new certifications for Paris Brain Institute’s core facilities
Paris Brain Institute’s core facilities were recently awarded two new certifications: ISO 9001 certification for ICM.Quant and ISO 20387 certification for its DNA & Cell Bank.
11.14.2025 Institutional
La dépression résistante possède une signature moléculaire spécifique
Treatment-resistant depression identified as a distinct molecular subtype
An international study published in Brain, Behavior, and Immunity shows that patients with treatment-resistant depression (TRD) have a unique biology, different from those who respond to standard therapies. More than 5,000 genes were found to behave...
11.03.2025 Research, science & health
See all our news